Anti-infective Market – Awareness of Anti-Infectives among End-Users such as Health Care Professionals and Clinicians and the Presence of Developed Health Care Infrastructure Which Drive the Market
Anti-infective agents are drugs used for the purpose of killing and/or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro parasites. Infections thus caused can be classified depending on type of organism causing the infection and symptoms and medical signs shown by the host.
Obtain Report Details @
The anti-infective market has been continuously expanding and the pharmaceutical sector generates higher profit margin than any other sector globally. Rise in the number of hospitals and primary care clinics also boosts the demand for anti-infective drugs. Currently, antimicrobial resistance is a major risk factor to the industry and as per the World Health Organization (WHO) last year, 480,000 people develop multi-drug resistance against tuberculosis drugs every year. Similarly, Staphylococcus aureus produces methicillin resistance in various region of the world. This is of paramount concern to the anti-infectives market at the present.
Request Report Brochure @
Key drivers of the anti-infective market include increase in the number of patients, new drug introductions, and significant number of vaccines gaining approvals. Rise in resistance of infection causing organisms to the existing drug therapies is anticipated to pose a major challenge to the anti-infective market. Furthermore, high price of drugs, dicey reimbursement policies, and competition between generic manufacturers are expected to hinder the growth of the anti-infective market. The anti-infective market is highly fragmented due to the presence of a large number of domestic and international players. The focus of developing anti-infective agents has shifted to antiviral agents due to requirement of longer treatment regimens in a large number of patients with chronic indications as compared to antibacterial and antifungal agents requiring shorter treatments.
Enquiry for Discount on this Report @
The global anti-infective market can be classified, based on product type, as antifungal, antiviral, and antibacterials. The antibacterials segment can be further divided into macrolides, cephalosporins, carbopenems, penicillins, quinolones, sulfonamides, tetracyclines, and others. Antibacterials is a high revenue generating segment as compared to the other segments due to the high prescription rates of the antibacterial products. The antifungals segment includes azoles, echinocandins, and polyenes.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The companyâ€™s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMRâ€™s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
Email: [email protected]